Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York C
about
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic locationMechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.Endogenous Candida endophthalmitis.Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility.CHROMagar Candida as the sole primary medium for isolation of yeasts and as a source medium for the rapid-assimilation-of-trehalose test.Pharmacokinetics of fosfluconazole and fluconazole following multiple intravenous administration of fosfluconazole in healthy male volunteers.Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).Susceptibility to antifungal agents of Candida species isolated from paediatric and adult patients with haematological diseases.Characterisation of an ABC transporter of a resistant Candida glabrata clinical isolate.
P2860
Q30452976-7BD0FB6B-C736-45D7-9EE3-F6E3F7179759Q33805788-68A84E35-190E-4538-8157-EB1E26B8BEF7Q34228354-388171FA-63A0-4C53-B553-361F904E1B90Q35714132-32ED8CE8-A462-479E-B92F-ECF772582E89Q36607424-3F4C4434-499B-4EFA-A115-98FD0AE88BC5Q41957394-851DEC10-F446-4D3F-982A-7D20615810E4Q42035138-0FCB35C7-4895-4631-B489-EF5483ABEEDEQ42284150-F851EF7B-0748-40FB-812D-82F8500F7D0BQ42545839-A49F4936-FF87-4364-8582-9A87D4123B2CQ44126999-D7AC0E75-2596-43D6-8DAD-3690EA3F371BQ46785730-38CE46E6-DB3B-4232-9E51-EEA3DE12C226Q50142221-DCFFFF12-8E41-487B-B2D0-8FDF5FA07049
P2860
Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York C
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prospective, multicenter surve ...... aching hospitals in New York C
@ast
Prospective, multicenter surve ...... aching hospitals in New York C
@en
Prospective, multicenter surve ...... aching hospitals in New York C
@nl
type
label
Prospective, multicenter surve ...... aching hospitals in New York C
@ast
Prospective, multicenter surve ...... aching hospitals in New York C
@en
Prospective, multicenter surve ...... aching hospitals in New York C
@nl
prefLabel
Prospective, multicenter surve ...... aching hospitals in New York C
@ast
Prospective, multicenter surve ...... aching hospitals in New York C
@en
Prospective, multicenter surve ...... aching hospitals in New York C
@nl
P2093
P2860
P921
P1476
Prospective, multicenter surve ...... aching hospitals in New York C
@en
P2093
Amar Safdar
Brian S Koll
David S Perlin
Davise H Larone
Donald Armstrong
Vishnu Chaturvedi
P2860
P304
P356
10.1128/AAC.46.10.3268-3272.2002
P407
P577
2002-10-01T00:00:00Z